CNBC Power July 4, 2024
Staggering. We will talk to the head of the National Organization for Rare Disorders about the scope of the problem but you might be surprised as i was. We will talk to the ceo of a Company Working in this area about the process for getting treatment approved and a look at some of the stocks involved in this opportunity to invest in Companies Working to treat or even cure these diseases. First, a check out the markets. The stocks are mixed following the latest on inflation we got this morning. We have the nasdaq composite up about 6 10 of a percent. The s p 500 a pretense. Nasdaq just about fl...